vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.
CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $49.9M, roughly 1.3× MARAVAI LIFESCIENCES HOLDINGS, INC.). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs -71.6%, a 105.6% gap on every dollar of revenue. Over the past eight quarters, CAMDEN NATIONAL CORP's revenue compounded faster (22.6% CAGR vs -11.9%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.
CAC vs MRVI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $49.9M |
| Net Profit | $21.9M | $-35.7M |
| Gross Margin | — | 25.8% |
| Operating Margin | — | -117.9% |
| Net Margin | 34.0% | -71.6% |
| Revenue YoY | — | -11.8% |
| Net Profit YoY | — | -37.7% |
| EPS (diluted) | $1.29 | $-0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $49.9M | ||
| Q3 25 | $65.4M | $41.6M | ||
| Q2 25 | $62.3M | $47.4M | ||
| Q1 25 | $60.1M | $46.9M | ||
| Q4 24 | $47.6M | $56.6M | ||
| Q3 24 | $45.0M | $69.0M | ||
| Q2 24 | $42.8M | $69.4M |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | $-35.7M | ||
| Q3 25 | $21.2M | $-25.6M | ||
| Q2 25 | $14.1M | $-39.6M | ||
| Q1 25 | $7.3M | $-29.9M | ||
| Q4 24 | $14.7M | $-25.9M | ||
| Q3 24 | $13.1M | $-97.1M | ||
| Q2 24 | $12.0M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 25.8% | ||
| Q3 25 | — | 13.6% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 16.5% | ||
| Q4 24 | — | 34.3% | ||
| Q3 24 | — | 46.7% | ||
| Q2 24 | — | 44.4% |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | -117.9% | ||
| Q3 25 | 40.5% | -98.6% | ||
| Q2 25 | 28.5% | -139.8% | ||
| Q1 25 | 10.3% | -104.9% | ||
| Q4 24 | 38.7% | -66.7% | ||
| Q3 24 | 35.2% | -239.9% | ||
| Q2 24 | 34.7% | -19.4% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | -71.6% | ||
| Q3 25 | 32.4% | -61.4% | ||
| Q2 25 | 22.6% | -83.5% | ||
| Q1 25 | 12.2% | -63.9% | ||
| Q4 24 | 30.8% | -45.8% | ||
| Q3 24 | 29.1% | -140.6% | ||
| Q2 24 | 28.0% | -14.1% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $-0.24 | ||
| Q3 25 | $1.25 | $-0.18 | ||
| Q2 25 | $0.83 | $-0.27 | ||
| Q1 25 | $0.43 | $-0.21 | ||
| Q4 24 | $1.00 | $-0.21 | ||
| Q3 24 | $0.90 | $-0.68 | ||
| Q2 24 | $0.81 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $216.9M |
| Total DebtLower is stronger | $514.4M | $291.8M |
| Stockholders' EquityBook value | $710.0M | $212.4M |
| Total Assets | $7.0B | $770.6M |
| Debt / EquityLower = less leverage | 0.72× | 1.37× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $216.9M | ||
| Q3 25 | — | $243.6M | ||
| Q2 25 | — | $269.9M | ||
| Q1 25 | — | $285.1M | ||
| Q4 24 | — | $322.4M | ||
| Q3 24 | — | $578.2M | ||
| Q2 24 | — | $573.2M |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | $291.8M | ||
| Q3 25 | — | $292.8M | ||
| Q2 25 | — | $293.9M | ||
| Q1 25 | — | $294.9M | ||
| Q4 24 | — | $295.9M | ||
| Q3 24 | — | $521.7M | ||
| Q2 24 | — | $522.5M |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $212.4M | ||
| Q3 25 | $676.4M | $245.4M | ||
| Q2 25 | $652.1M | $265.9M | ||
| Q1 25 | $640.1M | $300.6M | ||
| Q4 24 | $531.2M | $325.3M | ||
| Q3 24 | $529.9M | $344.9M | ||
| Q2 24 | $508.3M | $434.7M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $770.6M | ||
| Q3 25 | $7.0B | $849.2M | ||
| Q2 25 | $6.9B | $897.0M | ||
| Q1 25 | $7.0B | $959.8M | ||
| Q4 24 | $5.8B | $1.0B | ||
| Q3 24 | $5.7B | $1.3B | ||
| Q2 24 | $5.7B | $1.4B |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | 1.37× | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | 0.98× | ||
| Q4 24 | — | 0.91× | ||
| Q3 24 | — | 1.51× | ||
| Q2 24 | — | 1.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-22.8M |
| Free Cash FlowOCF − Capex | — | $-24.9M |
| FCF MarginFCF / Revenue | — | -49.9% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-70.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $-22.8M | ||
| Q3 25 | $36.1M | $-15.2M | ||
| Q2 25 | $6.0M | $-10.3M | ||
| Q1 25 | $1.0M | $-9.4M | ||
| Q4 24 | $60.9M | $-14.6M | ||
| Q3 24 | $-14.5M | $13.1M | ||
| Q2 24 | $14.5M | $17.4M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $-24.9M | ||
| Q3 25 | $35.4M | $-18.1M | ||
| Q2 25 | $4.5M | $-13.1M | ||
| Q1 25 | $-727.0K | $-14.6M | ||
| Q4 24 | $55.4M | $-20.5M | ||
| Q3 24 | $-16.2M | $4.5M | ||
| Q2 24 | $13.2M | $7.9M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | -49.9% | ||
| Q3 25 | 54.1% | -43.4% | ||
| Q2 25 | 7.3% | -27.7% | ||
| Q1 25 | -1.2% | -31.2% | ||
| Q4 24 | 116.4% | -36.2% | ||
| Q3 24 | -36.0% | 6.6% | ||
| Q2 24 | 30.8% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 4.2% | ||
| Q3 25 | 1.1% | 7.0% | ||
| Q2 25 | 2.4% | 6.1% | ||
| Q1 25 | 2.9% | 11.2% | ||
| Q4 24 | 11.7% | 10.3% | ||
| Q3 24 | 3.8% | 12.4% | ||
| Q2 24 | 3.0% | 13.8% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 4.15× | — | ||
| Q3 24 | -1.11× | — | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
